JP2006508951A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006508951A5 JP2006508951A5 JP2004550521A JP2004550521A JP2006508951A5 JP 2006508951 A5 JP2006508951 A5 JP 2006508951A5 JP 2004550521 A JP2004550521 A JP 2004550521A JP 2004550521 A JP2004550521 A JP 2004550521A JP 2006508951 A5 JP2006508951 A5 JP 2006508951A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- receptor antagonist
- glucocorticoid receptor
- migraine
- administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 26
- 229940126013 glucocorticoid receptor antagonist Drugs 0.000 claims 14
- 239000003850 glucocorticoid receptor antagonist Substances 0.000 claims 14
- 208000019695 Migraine disease Diseases 0.000 claims 10
- 206010027599 migraine Diseases 0.000 claims 10
- 230000037396 body weight Effects 0.000 claims 4
- VKHAHZOOUSRJNA-GCNJZUOMSA-N mifepristone Chemical group C1([C@@H]2C3=C4CCC(=O)C=C4CC[C@H]3[C@@H]3CC[C@@]([C@]3(C2)C)(O)C#CC)=CC=C(N(C)C)C=C1 VKHAHZOOUSRJNA-GCNJZUOMSA-N 0.000 claims 3
- 229960003248 mifepristone Drugs 0.000 claims 3
- 230000003637 steroidlike Effects 0.000 claims 3
- 239000000443 aerosol Substances 0.000 claims 2
- -1 dimethylaminophenyl moiety Chemical group 0.000 claims 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 2
- 239000007921 spray Substances 0.000 claims 2
- ZISSAWUMDACLOM-UHFFFAOYSA-N triptane Chemical compound CC(C)C(C)(C)C ZISSAWUMDACLOM-UHFFFAOYSA-N 0.000 claims 2
- YWROELXZPBSUCO-IYXRBSQSSA-N (2r)-1,2,3,4,4a,4b,5,6-octahydrophenanthrene-2,7-diol Chemical compound C12CCC(O)=CC2=CC=C2C1CC[C@@H](O)C2 YWROELXZPBSUCO-IYXRBSQSSA-N 0.000 claims 1
- ZCAUIZYRNPHJJO-CAMMJAKZSA-N (8s,10s,13s,14s)-10,13-dimethyl-1,2,6,7,8,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-one Chemical compound C([C@H]12)CC3=CC(=O)CC[C@]3(C)C1=CC[C@@]1(C)[C@H]2CCC1 ZCAUIZYRNPHJJO-CAMMJAKZSA-N 0.000 claims 1
- 125000000530 1-propynyl group Chemical group [H]C([H])([H])C#C* 0.000 claims 1
- 125000000590 4-methylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 claims 1
- 102000004328 Cytochrome P-450 CYP3A Human genes 0.000 claims 1
- 108010081668 Cytochrome P-450 CYP3A Proteins 0.000 claims 1
- 108010044467 Isoenzymes Proteins 0.000 claims 1
- 230000000069 prophylactic effect Effects 0.000 claims 1
- 239000000725 suspension Substances 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42419902P | 2002-11-05 | 2002-11-05 | |
| PCT/US2003/035328 WO2004041214A2 (en) | 2002-11-05 | 2003-11-05 | Methods for treating migraine |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010249214A Division JP2011021044A (ja) | 2002-11-05 | 2010-11-05 | 片頭痛を処置するための方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006508951A JP2006508951A (ja) | 2006-03-16 |
| JP2006508951A5 true JP2006508951A5 (enExample) | 2006-12-21 |
Family
ID=32312768
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004550521A Pending JP2006508951A (ja) | 2002-11-05 | 2003-11-05 | 片頭痛を処置するための方法 |
| JP2004550523A Pending JP2006507311A (ja) | 2002-11-05 | 2003-11-05 | 胃食道逆流性疾患を処置するための方法 |
| JP2010249214A Pending JP2011021044A (ja) | 2002-11-05 | 2010-11-05 | 片頭痛を処置するための方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004550523A Pending JP2006507311A (ja) | 2002-11-05 | 2003-11-05 | 胃食道逆流性疾患を処置するための方法 |
| JP2010249214A Pending JP2011021044A (ja) | 2002-11-05 | 2010-11-05 | 片頭痛を処置するための方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US7361646B2 (enExample) |
| EP (2) | EP1581234A4 (enExample) |
| JP (3) | JP2006508951A (enExample) |
| AU (2) | AU2003291314B2 (enExample) |
| CA (2) | CA2504751C (enExample) |
| WO (2) | WO2004041214A2 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8569277B2 (en) | 2004-08-11 | 2013-10-29 | Palo Alto Investors | Methods of treating a subject for a condition |
| US8324192B2 (en) | 2005-11-12 | 2012-12-04 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
| US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
| US8679545B2 (en) | 2005-11-12 | 2014-03-25 | The Regents Of The University Of California | Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract |
| CA2649894A1 (en) * | 2006-05-02 | 2007-11-15 | Corcept Therapeutics, Inc. | The use of a glucocorticoid receptor ii antagonist to treat depression in patients taking il-2 |
| CA2676670C (en) | 2007-02-02 | 2012-03-13 | Pfizer Products Inc. | Tricyclic compounds, compositions, and methods |
| ES2626131T3 (es) * | 2007-10-17 | 2017-07-24 | Laboratoire Hra Pharma | Antagonistas del receptor de glucocorticoides tales como mifepristona para tratar el síndrome de Cushing |
| US20090123551A1 (en) * | 2007-11-13 | 2009-05-14 | Meritage Pharma, Inc. | Gastrointestinal delivery systems |
| US20100216754A1 (en) * | 2007-11-13 | 2010-08-26 | Meritage Pharma, Inc. | Compositions for the treatment of inflammation of the gastrointestinal tract |
| US20090143343A1 (en) * | 2007-11-13 | 2009-06-04 | Meritage Pharma, Inc. | Compositions for the treatment of inflammation of the gastrointestinal tract |
| KR101245604B1 (ko) | 2007-11-13 | 2013-03-21 | 메리테이지 파마, 인크. | 코르티코스테로이드 조성물 |
| US20090264392A1 (en) * | 2008-04-21 | 2009-10-22 | Meritage Pharma, Inc. | Treating eosinophilic esophagitis |
| WO2010144865A2 (en) * | 2009-06-12 | 2010-12-16 | Meritage Pharma, Inc. | Methods for treating gastrointestinal disorders |
| US10500216B2 (en) | 2011-11-18 | 2019-12-10 | Corcept Therapeutics, Inc. | Optimizing mifepristone absorption |
| US20150209374A1 (en) | 2014-01-29 | 2015-07-30 | Faro Owiesy | Composition and Method for Curing Migraine Headaches |
| US9943526B2 (en) | 2015-04-21 | 2018-04-17 | Corcept Therapeutics, Inc. | Optimizing mifepristone levels for cushing's patients |
| MX383318B (es) | 2015-08-13 | 2025-03-13 | Corcept Therapeutics Inc | Metodo para diagnosticar de manera diferencial el sindrome de cushing dependiente de la corticotropina. |
| CA3011728A1 (en) | 2016-01-19 | 2017-07-27 | Corcept Therapeutics, Inc. | Differential diagnosis of ectopic cushing's syndrome |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2576025B1 (fr) * | 1985-01-14 | 1987-01-23 | Roussel Uclaf | Nouveaux steroides substitues en position 10, leur procede et les intermediaires de preparation, leur application comme medicaments, les compositions pharmaceutiques les contenant |
| FR2598421B1 (fr) | 1986-05-06 | 1988-08-19 | Roussel Uclaf | Nouveaux produits 19-nor ou 19-nor d-homo steroides substitues en position 11b par un radical phenyle portant un radical alkynyle, leur procede de preparation, leur application comme medicaments et les compositions les renfermant |
| US5250529A (en) * | 1990-02-08 | 1993-10-05 | Kos Pharmaceuticals, Inc. | Method alleviating migraine headache with mast cell degranulation blocking agents |
| US5468741A (en) * | 1993-05-28 | 1995-11-21 | The Regents Of The University Of California | Use of low levels of mifepristone to treat leiomyomata |
| US5521166A (en) * | 1994-12-19 | 1996-05-28 | Ortho Pharmaceitical Corporation | Antiprogestin cyclophasic hormonal regimen |
| IL118974A (en) | 1995-08-17 | 2001-09-13 | Akzo Nobel Nv | History 11 - (Transformed Phenyl) - Astra - 4, 9 - Diane, their preparation and pharmaceutical preparations containing them |
| US5914129A (en) * | 1996-07-23 | 1999-06-22 | Mauskop; Alexander | Analgesic composition for treatment of migraine headaches |
| US5697112A (en) * | 1996-11-08 | 1997-12-16 | Glaxo Wellcome Inc. | Therapy pillow useful for treating gastroesophageal reflux disease (gerd) and other applications |
| US6166013A (en) * | 1998-07-30 | 2000-12-26 | Abbott Laboratories | Glucocortiocoid-selective agents |
| HUP0201243A3 (en) | 1999-04-30 | 2002-11-28 | Pfizer Prod Inc | Glucocorticoid receptor modulators, pharmaceutical compositions containing them and their use |
| IL139197A0 (en) * | 1999-10-29 | 2001-11-25 | Pfizer Prod Inc | Use of corticotropin releasing factor antagonists and related compositions |
| US6579898B2 (en) | 2001-03-01 | 2003-06-17 | Pfizer Inc. | Compositions having improved bioavailability |
| AU2002361861A1 (en) * | 2001-12-21 | 2003-07-30 | Rhode Island Hospital | SELECTIVE 11Beta-HSD INHIBITORS AND METHODS FOR USE THEREOF |
-
2003
- 2003-11-05 CA CA2504751A patent/CA2504751C/en not_active Expired - Fee Related
- 2003-11-05 JP JP2004550521A patent/JP2006508951A/ja active Pending
- 2003-11-05 AU AU2003291314A patent/AU2003291314B2/en not_active Ceased
- 2003-11-05 JP JP2004550523A patent/JP2006507311A/ja active Pending
- 2003-11-05 WO PCT/US2003/035328 patent/WO2004041214A2/en not_active Ceased
- 2003-11-05 CA CA2504697A patent/CA2504697C/en not_active Expired - Fee Related
- 2003-11-05 EP EP03768706A patent/EP1581234A4/en not_active Withdrawn
- 2003-11-05 AU AU2003291322A patent/AU2003291322B2/en not_active Ceased
- 2003-11-05 EP EP03768714A patent/EP1567167A4/en not_active Ceased
- 2003-11-05 WO PCT/US2003/035341 patent/WO2004041215A2/en not_active Ceased
- 2003-11-05 US US10/702,950 patent/US7361646B2/en not_active Expired - Lifetime
- 2003-11-05 US US10/703,069 patent/US8450379B2/en active Active
-
2010
- 2010-11-05 JP JP2010249214A patent/JP2011021044A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006508951A5 (enExample) | ||
| JP2006507311A5 (enExample) | ||
| CA2157003C (en) | Hormone replacement therapy | |
| JP2005535664A5 (enExample) | ||
| CA2504697A1 (en) | Methods for treating migraine | |
| JP6175364B2 (ja) | 子宮内膜増殖を抑制するための組成物および方法 | |
| JP2001518509A5 (enExample) | ||
| JP2019163318A5 (enExample) | ||
| WO1999063973A3 (en) | PHARMACEUTICAL COMPOSITIONS AND USES FOR ANDROST-5-ENE-3β,17β-DIOL | |
| RU2001101492A (ru) | ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ АНДРОСТ-5-EH-3-β, 17β-ДИОЛ, И ЕГО ИСПОЛЬЗОВАНИЕ | |
| KR970704450A (ko) | 자궁내막증식증 또는 자궁평활근종을 치료하기 위한 프로게스테론 길항제 및 게스타겐의 용도(Use of a Progesterone Antagonist and of a Gestagen for the Treatment of Endometriosis or Leiomyomate Uteri) | |
| JP2010507685A5 (enExample) | ||
| CA2491296A1 (en) | Methods for treating psychosis associated with interferon-.alpha. therapy | |
| JP2011520820A (ja) | 婦人科系障害の治療のための、２０，２０，２１，２１，２１−ペンタフルオロ−１７−ヒドロキシ−１１β−［４−（ヒドロキシアセチル）フェニル］−１９−ノル−１７α−プレグナ−４，９−ジエン−３−オン、及び１又は複数のプロゲストゲンの連続投与 | |
| JP2003527342A5 (enExample) | ||
| CA2459033A1 (en) | Methods for inhibiting cognitive deterioration in adults with down's syndrome | |
| JP2006516651A5 (enExample) | ||
| RU2001118273A (ru) | 17β-ацил-17α-пропинил-11β-арилстероиды и их производные, обладающие агонистическими или антагонистическими гормональными свойствами | |
| JP2007505829A5 (enExample) | ||
| JPH07278017A (ja) | 麻薬又は麻薬混合物からの自然の又は早められた退薬症状と関連した徴候を予防し又は治療するための薬剤の製造への抗グルココルチコイド活性を有する化合物の使用及びそれらを含有する組成物 | |
| CN100531738C (zh) | (11β,17β)-11-(1,3-苯并间二氧杂环戊烯-5-基)-17-羟基-17-(1-丙炔基)雌-4,9-二烯-3-酮在治疗重性抑郁症中的应用 | |
| JP2005521637A5 (enExample) | ||
| CA2532415A1 (en) | Antiglucocorticoid therapy for the prevention of neurological damage in premature infants | |
| EA200501739A1 (ru) | Композиция, содержащая антагонисты рецептора прогестерона и чистые антиэстрогены, предназначенные для профилактики и лечения гормонзависимых заболеваний | |
| CA2248841C (en) | Sequential oestrogen/progesterone antagonist combination for hormone replacement therapy |